Download Mental Health Bulletin, July 2008

Sarcoma & Bone Cancer
January 2013
This bulletin covers sarcomas, soft tissue tumours and bone cancers, and should be of interest to
multidisciplinary teams working in this area.
Sections can include:







Combined Modality Therapies
Drug Therapy
Pathology, Staging, Polymorphisms & Biomarkers
Prognosis, Survival & Risk Factors
Radiotherapy & Imaging
Supportive Care & Symptom Management
Surgery
Many of the following articles are available online via the NHS Scotland Knowledge Network.
Please use the links where provided and your ATHENS password. A complete list of
available online journals and registration for ATHENS can be found at
www.knowledge.scot.nhs.uk/
If the article you require is not available via the NHS Scotland Knowledge Network and you
would like to request a print copy, please submit your request online at
www.quest.scot.nhs.uk
This bulletin contains a selection of material gathered from a search of the evidence base, and is
not intended to be comprehensive. Professional judgment should be exercised when appraising
the material. The Library takes no responsibility for the wording, content and accuracy of the
information supplied, which has been extracted in good faith from reputable sources. NHSGGC is
not responsible for the content of external internet sites.
Compiled by:
Kirsty Coltart
Subject Librarian
Beatson West of Scotland Cancer Centre
0141 301 7285, [email protected]
1
Sarcoma & Bone Cancers, January 2013
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
General
Bell, S.W., Young, P.S. and Mahendra, A. (2012). Primary bone tumours of the talus: the
Scottish Bone Tumour Registry experience. Journal of Foot & Ankle Surgery 18,4:277282.
Bloch, O. and Parsa, A.T. (2013). Skull base chondrosarcoma: evidence-based
treatment paradigms. Neurosurgery clinics of North America 24,1:89-96.
Kim, H.J., McLawhorn, A.S., Goldstein, M.J., et al. (2012). Malignant osseous tumors of
the pediatric spine. Journal of the American Academy of Orthopaedic Surgeons 20,10:646656.
Parida, L., Fernandez-Pineda, I., Uffman, J., et al. (2012). Clinical management of Ewing
sarcoma of the bones of the hands and feet: a retrospective single-institution
review. Journal of pediatric surgery 47,10:1806-1810.
Rakha, E.A., Tan, P.H., Shaaban, A., et al. (2013). Do primary mammary osteosarcoma
and chondrosarcoma exist? A review of a large multi-institutional series of
malignant matrix-producing breast tumours. Breast 22,1:13-18.
Stanelle, E.J., Christison-Lagay, E.R., Healey, J.H., et al. (2013). Pediatric and adolescent
synovial sarcoma: multivariate analysis of prognostic factors and survival
outcomes. Annals of Surgical Oncology 20,1:73-79.
Combined Modality Therapies
Denbo, J.W., Shannon Orr, W., Wu, Y., et al. (2012). Timing of surgery and the role of
adjuvant radiotherapy in ewing sarcoma of the chest wall: a single-institution
experience. Annals of Surgical Oncology 19,12:3809-3815.
Dharmarajan, K.V., Wexler, L.H. and Wolden, S.L. (2013). Concurrent radiation with
irinotecan and carboplatin in intermediate- and high-risk rhabdomyosarcoma: A
report on toxicity and efficacy from a prospective pilot phase II study. Pediatric
Blood & Cancer 60,2:242-247.
Woll, P.J., Reichardt, P., Le Cesne, A., et al. (2012). Adjuvant chemotherapy with
doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC
62931): a multicentre randomised controlled trial. Lancet Oncology 13,10:1045-1054.
Drug & Targeted Therapy
Bernthal, N.M., Federman, N., Eilber, F.R., et al. (2012). Long-term results (>25 years)
of a randomized, prospective clinical trial evaluating chemotherapy in patients with
high-grade, operable osteosarcoma. Cancer 118,23:5888-5893.
Indelicato, D.J. and Finkelstein, S.E. (2012). Dendritic cell immunotherapy in soft tissue
sarcoma. Immunotherapy 4,10:1023-1029.
Le Cesne, A., Cresta, S., Maki, R.G., et al. (2012). A retrospective analysis of
antitumour activity with trabectedin in translocation-related sarcomas. European
journal of cancer 48,16:3036-3044.
2
Sarcoma & Bone Cancers, January 2013
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Leahy, M., Garcia Del Muro, X., Reichardt, P., et al. (2012). Chemotherapy treatment
patterns and clinical outcomes in patients with metastatic soft tissue sarcoma. The
SArcoma treatment and Burden of Illness in North America and Europe (SABINE)
study. Annals of Oncology 23,10:2763-2770.
Mulder, R.L., Paulides, M., Langer, T., et al. (2012). Cyclophosphamide versus ifosfamide
for paediatric and young adult bone and soft tissue sarcoma patients. Cochrane
Database of Systematic Reviews 12,006300.
Womer, R.B., West, D.C., Krailo, M.D., et al. (2012). Randomized Controlled Trial of
Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma:
A Report From the Children's Oncology Group. Journal of Clinical Oncology 30,33:41484154.
Pathology, Staging, Polymorphisms & Biomarkers
Flores, R.J., Li, Y., Yu, A., et al. (2012). A systems biology approach reveals common
metastatic pathways in osteosarcoma. BMC Systems Biology 6,50.
Janeway, K.A. and Maki, R.G. (2012). New strategies in sarcoma therapy: linking
biology and novel agents. Clinical Cancer Research 18,21:5837-5844.
Kamiya, N., Suzuki, H., Endo, T., et al. (2012). Clinical usefulness of bone markers in
prostate cancer with bone metastasis. International Journal of Urology 19,11:968-979.
Stacchiotti, S., Verderio, P., Messina, A., et al. (2012). Tumor response assessment by
modified Choi criteria in localized high-risk soft tissue sarcoma treated with
chemotherapy. Cancer 118,23:5857-5866.
Wright, S., Armeson, K., Hill, E.G., et al. (2012). The role of sentinel lymph node biopsy
in select sarcoma patients: a meta-analysis. American Journal of Surgery 204,4:428433.
Prognosis, Survival & Risk Factors
Chan, J.Y., Wong, S.T., Lau, G.I., et al. (2012). Postradiation sarcoma after
radiotherapy for nasopharyngeal carcinoma. Laryngoscope 122,12:2695-2699.
Choi, A.H., Barnholtz-Sloan, J.S. and Kim, J.A. (2012). Effect of radiation therapy on
survival in surgically resected retroperitoneal sarcoma: a propensity score-adjusted
SEER analysis. Annals of Oncology 23,9:2449-2457.
Hendifar, A.E., Ahlmann, E., Allison, D.C., et al. (2012). Moving beyond response criteria:
new measures of success in the treatment of sarcomas. Current Treatment Options in
Oncology 13,3:299-305.
Khaliq, W., Meyer, C.F., Uzoaru, I., et al. (2012). Prostate angiosarcoma: is there any
association with previous radiation therapy?. BJU international 110,11:E819-25.
Morgan, E.A., Kozono, D.E., Wang, Q., et al. (2012). Cutaneous radiation-associated
angiosarcoma of the breast: poor prognosis in a rare secondary malignancy. Annals
of Surgical Oncology 19,12:3801-3808.
3
Sarcoma & Bone Cancers, January 2013
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Radiotherapy & Imaging
Garg, A.K., Shiu, A.S., Yang, J., et al. (2012). Phase 1/2 trial of single-session
stereotactic body radiotherapy for previously unirradiated spinal metastases.
Cancer 118,20:5069-5077.
Haas, R.L., Delaney, T.F., O'Sullivan, B., et al. (2012). Radiotherapy for management of
extremity soft tissue sarcomas: why, when, and where? International journal of
radiation oncology, biology, physics 84,3:572-580.
McGee, L., Indelicato, D.J., Dagan, R., et al. (2012). Long-term results following
postoperative radiotherapy for soft tissue sarcomas of the extremity. International
journal of radiation oncology, biology, physics 84,4:1003-1009.
Soldatos, T., Chalian, M., Attar, S., et al. (2013). Imaging differentiation of pathologic
fractures caused by primary and secondary bone tumors. European Journal of
Radiology 82,1:e36-42.
Roeder, F., Schulz-Ertner, D., Nikoghosyan, A.V., et al. (2012). A clinical phase I/II trial
to investigate preoperative dose-escalated intensity-modulated radiation therapy
(IMRT) and intraoperative radiation therapy (IORT) in patients with retroperitoneal
soft tissue sarcoma. BMC Cancer 12,287.
Weksberg, D.C., Palmer, M.B., Vu, K.N., et al. (2012). Generalizable class solutions for
treatment planning of spinal stereotactic body radiation therapy. International journal
of radiation oncology, biology, physics 84,3:847-853.
Supportive Care & Symptom Management
Brodowicz, T., O'Byrne, K. and Manegold, C. (2012). Bone matters in lung cancer. Annals
of Oncology 23,9:2215-2222.
Fitzpatrick, D., Grabarz, D., Wang, L., et al. (2012). How effective is a virtual
consultation process in facilitating multidisciplinary decision-making for malignant
epidural spinal cord compression?. International journal of radiation oncology, biology,
physics 84,2:e167-72.
Hadji, P., Aapro, M., Costa, L., et al. (2012). Antiresorptive treatment options and bone
health in cancer patients-safety profiles and clinical considerations. Cancer treatment
reviews 38,6:815-824.
Lipton, A., Fizazi, K., Stopeck, A.T., et al. (2012). Superiority of denosumab to
zoledronic acid for prevention of skeletal-related events: a combined analysis of 3
pivotal, randomised, phase 3 trials. European journal of cancer 48,16:3082-3092.
Morgans, A.K. and Smith, M.R. (2012). Bone-targeted agents: preventing skeletal
complications in prostate cancer. Urologic Clinics of North America 39,4:533-546.
Peddi, P., Lopez-Olivo, M.A., Pratt, G.F., et al. (2013). Denosumab in patients with
cancer and skeletal metastases: A systematic review and meta-analysis. Cancer
treatment reviews 39,1:97-104.
So, A., Chin, J., Fleshner, N., et al. (2012). Management of skeletal-related events in
patients with advanced prostate cancer and bone metastases: Incorporating new
agents into clinical practice. Canadian Urological Association Journal 6,6:465-470.
4
Sarcoma & Bone Cancers, January 2013
Kirsty Coltart, Subject Librarian, NHSGGC Library Network
Zeng, L., Chow, E., Bedard, G., et al. (2012). Quality of life after palliative radiation
therapy for patients with painful bone metastases: results of an international study
validating the EORTC QLQ-BM22. International journal of radiation oncology, biology,
physics 84,3:e337-42.
Zeng, L., Chow, E., Zhang, L., et al. (2012). An international prospective study
establishing minimal clinically important differences in the EORTC QLQ-BM22 and
QLQ-C30 in cancer patients with bone metastases. Supportive Care in Cancer
20,12:3307-3313.
Surgery
Di Maio, S., Ramanathan, D., Garcia-Lopez, R., et al. (2012). Evolution and future of skull
base surgery: the paradigm of skull base meningiomas. World Neurosurgery 78,34:260-275.
Eastley, N., Newey, M. and Ashford, R.U. (2012). Skeletal metastases - the role of the
orthopaedic and spinal surgeon. Surgical oncology 21,3:216-222.
Hasan, K., Racano, A., Deheshi, B., et al. (2012). Prophylactic antibiotic regimens in
tumor surgery (PARITY) survey. BMC Musculoskeletal Disorders 13,91.
Malviya, A. and Gerrand, C. (2012). Evidence for orthopaedic surgery in the treatment
of metastatic bone disease of the extremities: a review article. Palliative medicine
26,6:788-796.
Vinals, J.M., Rodrigues, T.A., Sildenikova, D.P., et al. (2012). Indications of microsurgery
in soft tissue sarcomas. Journal of reconstructive microsurgery 28,9:619-625.
Zhang, T., Li, W., Dai, C., et al. (2013). Evidence-based surgical management of T1 or
T2 temporal bone malignancies. Laryngoscope 123,1:244-248.
Please note that the journal articles you are accessing are subject to the terms and conditions
imposed by the publisher, so there will be a limit on the number of articles an individual may
download or print from a single issue of a journal. You can consult your local NHSGGC library with
any queries.
If you have any questions regarding this or any other library services please contact Library staff –
contact details are at the beginning of the bulletin.
Sources used for this bulletin:
OVID databases
5
Sarcoma & Bone Cancers, January 2013
Kirsty Coltart, Subject Librarian, NHSGGC Library Network